| Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4 (3H)-one derivatives as potential PPARγ and SUR agonists MK Ibrahim, IH Eissa, MS Alesawy, AM Metwaly, MM Radwan, ... Bioorganic & medicinal chemistry 25 (17), 4723-4744, 2017 | 86 | 2017 |
| Design and synthesis of thiazolidine-2, 4-diones hybrids with 1, 2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: In-vitro anticancer evaluation and in … MS Taghour, H Elkady, WM Eldehna, NM El-Deeb, AM Kenawy, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 1903-1917, 2022 | 70 | 2022 |
| Design and discovery of new 1,2,4‐triazolo[4,3‐c]quinazolines as potential DNA intercalators and topoisomerase II inhibitors MS Alesawy, AA Al‐Karmalawy, EB Elkaeed, M Alswah, A Belal, ... Archiv Der Pharmazie 354 (3), 2000237, 2021 | 64 | 2021 |
| In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) MS Alesawy, AE Abdallah, MS Taghour, EB Elkaeed, I H. Eissa, ... Molecules 26 (9), 2806, 2021 | 55 | 2021 |
| [1, 2, 4] Triazolo [4, 3-c] quinazoline and bis ([1, 2, 4] triazolo)[4, 3-a: 4′, 3′-c] quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile … K El-Adl, MK Ibrahim, MSI Alesawy, IH Eissa Bioorganic & Medicinal Chemistry 30, 115958, 2021 | 55 | 2021 |
| Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2 AM El-Naggar, AMA Hassan, EB Elkaeed, MS Alesawy, AA Al‐Karmalawy Bioorganic Chemistry 123, 105770, 2022 | 53 | 2022 |
| Design and synthesis of new 4-(2-nitrophenoxy) benzamide derivatives as potential antiviral agents: Molecular modeling and in vitro antiviral screening AE Abdallah, MS Alesawy, SI Eissa, EM El-Fakharany, MH Kalaba, ... New Journal of Chemistry 45 (36), 16557-16571, 2021 | 48 | 2021 |
| In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking … MS Alesawy, EB Elkaeed, AA Alsfouk, AM Metwaly, IH Eissa Molecules 26 (21), 6593, 2021 | 39 | 2021 |
| Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2′-o-Methyltransferase Complex Inhibitors among 3009 … IH Eissa, MS Alesawy, AM Saleh, EB Elkaeed, BA Alsfouk, AAMM El-Attar, ... Molecules 27 (7), 2287, 2022 | 38 | 2022 |
| Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2, 4-diones targeting VEGFR-2 and apoptosis pathway MS Taghour, H Elkady, WM Eldehna, N El-Deeb, AM Kenawy, ... PLoS One 17 (9), e0272362, 2022 | 31 | 2022 |
| Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors AE Abdallah, RR Mabrouk, MMS Al Ward, SI Eissa, EB Elkaeed, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 573-591, 2022 | 29 | 2022 |
| Ligand-based design and synthesis of N'-Benzylidene-3, 4-dimethoxybenzohydrazide derivatives as potential antimicrobial agents; evaluation by in vitro, in vivo, and in silico … RR Ezz Eldin, MA Saleh, MH Alotaibi, RK Alsuair, YA Alzahrani, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 1098-1119, 2022 | 26 | 2022 |
| Anticancer derivative of the natural alkaloid, theobromine, inhibiting EGFR protein: Computer-aided drug discovery approach IH Eissa, RG Yousef, EB Elkaeed, AA Alsfouk, DZ Husein, IM Ibrahim, ... Plos one 18 (3), e0282586, 2023 | 9 | 2023 |
| Discovery of potential SARS-CoV-2 papain-like protease natural inhibitors employing a multi-phase In Silico approach EB Elkaeed, AM Metwaly, MS Alesawy, AM Saleh, AA Alsfouk, IH Eissa Life 12 (9), 1407, 2022 | 9 | 2022 |
| Design, synthesis, in silico ADMET, docking, and antiproliferative evaluations of [1,2,4]triazolo[4,3‐c]quinazolines as classical DNA intercalators MS Alesawy, MK Ibrahim, IH Eissa, K El‐Adl Archiv der Pharmazie 355 (4), 2100412, 2022 | 9 | 2022 |
| Triazoloquinazoline derived classical DNA intercalators: Design, synthesis, in silico ADME profile, docking, and antiproliferative evaluations K El‐Adl, MK Ibrahim, MS Alesawy, IH Eissa Archiv der Pharmazie 355 (6), 2100506, 2022 | 8 | 2022 |
| Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking IH Eissa, MK Ibrahim, MS Alesawy, K El‐Adl Archiv der Pharmazie 355 (5), 2100487, 2022 | 8 | 2022 |
| New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking … AE Azab, MS Alesawy, WM Eldehna, A Elwan, IH Eissa Archiv der Pharmazie 355 (10), 2200133, 2022 | 7 | 2022 |
